Immunohistochemistry Markers As Predictors Of Tissue Response To Radiochemotherapy In Rectal Cancer: Preliminary Results

Background: Preoperative Chemoradiotherapy is widely used to treat locally advanced rectal cancer, esophageal cancer, gastric cancer, and other cancers, with varying success rates and response patterns. Long has the medical literature sought to establish an accurate predictive model for the response of rectal cancer tumors to neoadjuvant therapy and nowadays, even artificial intelligence and deep machine learning have been employed to help in this direction.